Free Trial
OTCMKTS:BCYP

Big Cypress Acquisition (BCYP) Stock Price, News & Analysis

Big Cypress Acquisition logo
$8.44 -2.01 (-19.23%)
As of 10/22/2021

About Big Cypress Acquisition Stock (OTCMKTS:BCYP)

Key Stats

Today's Range
$8.21
$12.90
50-Day Range
$8.44
$8.44
52-Week Range
$8.21
$12.90
Volume
15.34 million shs
Average Volume
160,982 shs
Market Capitalization
$124.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BCYP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Big Cypress Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BCYP Stock News Headlines

Critical AI announcement set to ignite AI 2.0
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
Solar Stock Losers in Sharp's Big U.S. Acquisition
Big Ass Fans
SAB Biotherapeutics Inc
See More Headlines

BCYP Stock Analysis - Frequently Asked Questions

Big Cypress Acquisition's stock was trading at $8.44 on January 1st, 2025. Since then, BCYP stock has increased by 0.0% and is now trading at $8.44.

Big Cypress Acquisition Corp. (OTCMKTS:BCYP) posted its earnings results on Tuesday, November, 11th. The technology company reported ($0.01) EPS for the quarter, meeting analysts' consensus estimates of ($0.01). The technology company had revenue of $0.31 million for the quarter, compared to the consensus estimate of $0.21 million.

Shares of BCYP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Big Cypress Acquisition investors own include FuelCell Energy (FCEL), Onconova Therapeutics (ONTX), Co-Diagnostics (CODX), iBio (IBIO), Tonix Pharmaceuticals (TNXP), Vaxart (VXRT) and Adamis Pharmaceuticals (ADMP).

Company Calendar

Last Earnings
11/11/2014
Today
7/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
Personal Services
Current Symbol
OTCMKTS:BCYP
CIK
1399587
Fax
N/A
Employees
17
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.13
Quick Ratio
6.13

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
14,792,000
Free Float
N/A
Market Cap
$124.84 million
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (OTCMKTS:BCYP) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners